Ascendiant Capital Maintains Buy on Daxor, Raises Price Target to $24.75
Portfolio Pulse from Benzinga Newsdesk
Ascendiant Capital has maintained a Buy rating on Daxor (NASDAQ:DXR) and raised its price target from $24.5 to $24.75, indicating a positive outlook for the company's stock.
September 09, 2024 | 9:57 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Ascendiant Capital has maintained a Buy rating on Daxor and increased the price target to $24.75, suggesting a positive short-term outlook for the stock.
The increase in the price target from $24.5 to $24.75 by Ascendiant Capital, along with the maintained Buy rating, indicates a positive sentiment from analysts. This is likely to boost investor confidence and could lead to a short-term increase in DXR's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100